Literature DB >> 16563957

Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI.

Giulio Gambarota1, Hanneke W M van Laarhoven, Marielle Philippens, Jasper Lok, Albert van der Kogel, Cornelius J A Punt, Arend Heerschap.   

Abstract

OBJECTIVES: The characterization of tumor vasculature is essential in studying tumor physiology. The aim of this study was to develop a new method - based on water proton MR density measurements, in combination with ultrasmall superparamagnetic iron oxide (USPIO) administration - to measure absolute blood volume (BV) in murine colon carcinoma.
MATERIALS AND METHODS: MRI experiments were performed at 7 T. CPMG imaging was performed on subcutaneous murine colon carcinoma in six mice before and after administration of an USPIO blood-pool contrast agent. Density maps were obtained from the signal amplitude at TE=0 of the CPMG decay fit. Post-USPIO density maps were subtracted from pre-USPIO density maps to quantitatively yield absolute tumor BV maps. In a separate group of mice (n=6), the relative vascular area (RVA) of tumors was determined by immunohistochemistry.
RESULTS: Ultrasmall superparamagnetic iron oxide administration resulted in a small decrease in the water proton MR density. The BV averaged over the six tumors was 4.6+/-1.6%. The value of the RVA measured by immunohistochemical staining was equal to 3.9+/-2.2%.
CONCLUSIONS: After administration of an USPIO blood-pool agent (T(2) relaxivity > 100 mM(-1) s(-1)), the blood water protons become MRI invisible, and pixel-by-pixel BV map can be obtained by subtracting the calculated post-USPIO density map from the pre-USPIO density map. The value of absolute BV obtained with this novel MR approach is in good agreement with the value of the relative vascular measured by immunohistochemical staining.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563957     DOI: 10.1016/j.mri.2005.12.003

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  8 in total

1.  Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma.

Authors:  Giulio Gambarota; H W M van Laarhoven; M Philippens; W J M Peeters; P Rijken; A van der Kogel; C J A Punt; A Heerschap
Journal:  Appl Magn Reson       Date:  2010-03-28       Impact factor: 0.831

Review 2.  Functional MRI and CT biomarkers in oncology.

Authors:  J M Winfield; G S Payne; N M deSouza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-13       Impact factor: 9.236

3.  Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering.

Authors:  Rheal A Towner; Nataliya Smith; Yasuko Asano; Ting He; Sabrina Doblas; Debra Saunders; Robert Silasi-Mansat; Florea Lupu; Charles E Seeney
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

4.  Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.

Authors:  Kee H Wong; Rafal Panek; Alex Dunlop; Dualta Mcquaid; Angela Riddell; Liam C Welsh; Iain Murray; Dow-Mu Koh; Martin O Leach; Shreerang A Bhide; Christopher M Nutting; Wim J Oyen; Kevin J Harrington; Kate L Newbold
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-21       Impact factor: 9.236

5.  Accuracy of Tumor Perfusion Assessment in Rat C6 Gliomas Model with USPIO.

Authors:  Xiang-Rong Yu; Bo-Ling Cao; Wei Li; Ye Tian; Zhong-Li Du
Journal:  Open Med (Wars)       Date:  2019-11-07

6.  Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.

Authors:  G Gambarota; W Leenders; C Maass; P Wesseling; B van der Kogel; O van Tellingen; A Heerschap
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

7.  Comparison of T2 and T2*-weighted MR molecular imaging of a mouse model of glioma.

Authors:  Barbara Blasiak; Samuel Barnes; Tadeusz Foniok; David Rushforth; John Matyas; Dragana Ponjevic; Wladyslaw P Weglarz; Randy Tyson; Umar Iqbal; Abedelnasser Abulrob; Garnette R Sutherland; Andre Obenaus; Boguslaw Tomanek
Journal:  BMC Med Imaging       Date:  2013-07-18       Impact factor: 1.930

8.  Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T.

Authors:  Rafal Panek; Liam Welsh; Alex Dunlop; Kee H Wong; Angela M Riddell; Dow-Mu Koh; Maria A Schmidt; Simon Doran; Dualta Mcquaid; Georgina Hopkinson; Cheryl Richardson; Christopher M Nutting; Shreerang A Bhide; Kevin J Harrington; Simon P Robinson; Kate L Newbold; Martin O Leach
Journal:  J Magn Reson Imaging       Date:  2016-01-22       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.